-
-
-
-
-
-
-
Cantor Fitzgerald Starts Aligos Therapeutics Inc. (ALGS) at Overweight
-
-
-
-
-
-
-
Aligos Therapeutics Inc. (ALGS) Misses Q4 EPS by 191c
-
-
-
-
-
-
-
H.C. Wainwright Assumes Aligos Therapeutics Inc. (ALGS) at Buy
-
-
-
-
-
-
-
Aligos Therapeutics (ALGS) Presents Positive Data at The Liver Meeting
-
-
-
-
-
-
-
Aligos Therapeutics Inc. (ALGS) to Report Data from Phase 2a HERALD Study of ALG-055009 for the Treatment of MASH on September 19, 2024
-
-
-
-
435,282 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

